What are the main uses and benefits of Anemarrhena asphodeloides (Zhi Mu)?

Anemarrhena asphodeloides, known as Zhi Mu in Traditional Chinese Medicine (TCM), is primarily used to clear heat, nourish yin, and moisten dryness. It is a key ingredient in classic formulas like Bai Hu Tang and Zhi Bai Di Huang Wan. Practitioners prescribe it for symptoms associated with kidney yin deficiency, such as deficiency heat sweats, irritability, and dry coughs, as well as for quenching thirst and reducing lung or stomach fire (Traditional use).

How does Anemarrhena asphodeloides work to reduce inflammation?

Research suggests that Anemarrhena asphodeloides works through active compounds like sarsasapogenin, timosaponin AIII, and mangiferin. These constituents demonstrate anti-inflammatory and antioxidant properties by modulating inflammatory cytokines and protecting cellular function (Evidence Level C). In TCM theory, this mechanism correlates with its ability to clear excess heat and nourish yin, addressing the underlying inflammatory state.

What is the standard dosage for Anemarrhena asphodeloides?

The standard adult dosage for Anemarrhena asphodeloides is typically 6-12 grams of dried rhizome daily, usually prepared as a decoction. For standardized extracts, a dosage of 300-600 mg daily is common (Traditional use). Dosage may vary depending on the specific formulation and the patient's constitution; therefore, it is best to follow the guidance of a qualified practitioner.

Is Anemarrhena asphodeloides safe to take during pregnancy?

No, Anemarrhena asphodeloides is considered unsafe during pregnancy. Due to its cold and bitter properties, it is traditionally contraindicated for pregnant women as it may stimulate uterine contractions or disrupt the pregnancy. Women who are pregnant or breastfeeding should avoid this herb unless specifically directed by a qualified healthcare provider.

Does Anemarrhena asphodeloides interact with any medications?

Yes, Anemarrhena asphodeloides may interact with antidiabetic medications. Because the herb can lower blood glucose levels, combining it with insulin or oral hypoglycemic drugs may increase the risk of hypoglycemia (Evidence Level C). Patients taking blood thinners should also exercise caution due to potential anti-platelet effects associated with its saponin content. Always consult a physician before combining herbs with prescription drugs.

Huang Qi Zhi Mu (Anemarrhena asphodeloides)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Anemarrhena asphodeloides (Zhi-mu) is a traditional East Asian medicinal plant used to treat inflammatory, respiratory, and metabolic conditions [PMID:36330891, PMID:39476924].

Background

Anemarrhena asphodeloides Bunge, belonging to the Liliaceae or Asparagaceae family, is a rhizomatous plant predominantly found in China and Korea [PMID:36330891, PMID:24556224, PMID:40286959].

Traditional uses

It has been used in traditional Chinese medicine as a tonic agent and for treating arthralgia, hematochezia, tidal fever, night sweats, cough, dry mouth, tongue issues, and hemoptysis [PMID:36330891, PMID:24556224].

Active compounds

Key constituents include steroidal saponins (such as Timosaponin AIII, Timosaponin B-II, and Timosaponin V/W) [PMID:37863004, PMID:41308387, PMID:31866546], polysaccharides (including fructans) [PMID:40484257, PMID:31826524], xanthones (such as mangiferin) [PMID:35198747], flavones, cyclic peptides, and fatty acids [PMID:28666227].

Mechanism of action

Mechanisms include the induction of lipid peroxidation and ferroptosis via Rab7-mediated lipophagy in cancer cells [PMID:37863004], activation of the Akt/mTOR pathway and inhibition of the ubiquitin-proteasome pathway to attenuate muscle atrophy [PMID:40484257], and regulation of the PTGS2/EP2/cAMP/Epac1 signaling pathway to reduce microglial M1 polarization in depression [PMID:40216047]. It also acts by enhancing Parkin-mediated mitophagy in cerebral ischemia [PMID:41308387] and targeting S100A8 to inhibit neutrophil infiltration in MASH [PMID:40976053].

Clinical evidence

Evidence DColorectal Cancer

Timosaponin AIII induces ferroptosis and suppresses CRC cells through lipophagy [PMID:37863004]

Evidence DAtopic Dermatitis

Topical application of AA ointment alleviated symptoms, reduced epidermal thickness, and suppressed TSLP and TARC expression [PMID:39391467]

Evidence DAsthma

A herb pair of Zhimu and Chuanbeimu showed an obvious anti-asthma effect in rats, superior to either herb alone [PMID:40453213]

Evidence DInsulin Resistance

Anemarrhena saponins attenuated insulin resistance in high-fat diet-induced obese rats via the IRS-1/PI3K/AKT pathway [PMID:34052350]

Evidence DDepression

Combinations of Anemarrhena asphodeloides with Phellodendri Chinensis Cortex ameliorated CUMS-induced despair behaviors and reduced neuroinflammation [PMID:40216047, PMID:39904199]

Evidence DMuscle Atrophy

Evidence summary

The current evidence is primarily based on in vitro studies and animal models (Level D), demonstrating broad pharmacological potential in anti-inflammatory, anti-tumor, and metabolic regulation, though clinical trial data is lacking in the provided abstracts.

PubMed sources

1.PMID: 39736250 (2025) — Bioinformatics identification based on causal association inference using multi-omics reveals the underlying mechanism of Gui-Zhi-Shao-Yao-Zhi-Mu decoction in modulating rheumatoid arthritis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
2.PMID: 37863004 (2024) — Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. · Phytomedicine : international journal of phytotherapy and phytopharmacology
3.PMID: 36330891 (2023) — A review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicology and quality of Anemarrhena asphodeloides Bunge. · Journal of ethnopharmacology
4.PMID: 39476924 (2024) — Advances in the study of polysaccharides from Anemarrhena asphodeloides Bge.: A review. · International journal of biological macromolecules
5.PMID: 24556224

Huang Qi Zhi Mu

Sources & Citations